Zobrazeno 1 - 10
of 318
pro vyhledávání: '"Rabella, M"'
Autor:
Acevedo, A., Anglès, J., Argany, M.A., Barajas, A., Barrigón, M.L., Beltrán, M., Birulés, I., Bogas, J.L., Camprubí, N., Carbonero, M., Carmona Farrés, C., Carrasco, E., Casañas, R., Cid, J., Conesa, E., Corripio, I., Cortes, P., Crosas, J.M., de Apraiz, A., Delgado, M., Domínguez, L., Escartí, M.J., Escudero, A., Esteban Pinos, I., Figueras, M., Franco, C., García, C., Gil, V., Giménez-Díaz, D., Gonzalez-Casares, R., González Higueras, F., González- Montoro, MaL., González, E., Grasa Bello, E., Guasp, A., Huerta-Ramos, Ma E., Huertas, P., Jiménez-Díaz, A., Lalucat, L.L., LLacer, B., López-Alcayada, R., López- Carrilero, R., Lorente, E., Luengo, A., Mantecón, N., Mas-Expósito, L., Montes, M., Moritz, S., Murgui, E., Nuñez, M., Ochoa, S., Palomer, E., Paniego, E., Peláez, T., Pérez, V., Planell, K., Planellas, C., Pleguezuelo-Garrote, P., Pousa, E., Rabella, M., Renovell, M., Rubio, R., Ruiz- Delgado, I., San Emeterio, M., Sánchez, E., Sanjuán, J., Sans, B., Schilling, L., Sió, H., Teixidó, M., Torres, P., Vila, M.A., Vila-Badia, R., Villegas, F., Villellas, R., Sastre-Buades, Aina, Ochoa, Susana, Lorente-Rovira, Esther, Barajas, Ana, Grasa, Eva, López-Carrilero, Raquel, Luengo, Ana, Ruiz-Delgado, Isabel, Cid, Jordi, González-Higueras, Fermín, Sánchez-Alonso, Sergio, Baca-García, Enrique, Barrigón, Maria L.
Publikováno v:
In Journal of Psychiatric Research May 2021 137:514-520
Autor:
Pétremand R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Chiffelle J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Bobisse S; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Perez MAS; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Molecular Modelling Group, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Schmidt J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Arnaud M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Barras D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Lozano-Rabella M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Genolet R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Sauvage C; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Saugy D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Michel A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Huguenin-Bergenat AL; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Capt C; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Moore JS; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland., De Vito C; Division of Clinical Pathology, Department of Diagnostics, Hôpitaux Universitaires de Genève, Geneva, Switzerland., Labidi-Galy SI; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland.; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland., Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Dangaj Laniti D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Oliveira G; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wu CJ; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Immuno-oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Zoete V; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Molecular Modelling Group, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Harari A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland. alexandre.harari@chuv.ch.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland. alexandre.harari@chuv.ch.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2024 Jun 25. Date of Electronic Publication: 2024 Jun 25.
Autor:
Pétremand R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Chiffelle J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Bobisse S; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Perez MAS; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Molecular Modelling Group, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Schmidt J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Arnaud M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Barras D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Lozano-Rabella M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Genolet R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Sauvage C; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Saugy D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Michel A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Huguenin-Bergenat AL; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Capt C; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Moore JS; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland., De Vito C; Division of Clinical Pathology, Department of Diagnostics, Hôpitaux Universitaires de Genève, Geneva, Switzerland., Labidi-Galy SI; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland.; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland., Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Dangaj Laniti D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Oliveira G; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wu CJ; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Immuno-oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Zoete V; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Molecular Modelling Group, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Harari A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland. alexandre.harari@chuv.ch.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland. alexandre.harari@chuv.ch.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2024 May 07. Date of Electronic Publication: 2024 May 07.
Autor:
Lozano-Rabella M; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Garcia-Garijo A; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Palomero J; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Yuste-Estevanez A; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Erhard F; Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany., Farriol-Duran R; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Martín-Liberal J; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Ochoa-de-Olza M; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Matos I; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Gartner JJ; Surgery Branch, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland., Ghosh M; Institute for Cell Biology Department of Immunology, University of Tübingen, Tübingen, Germany., Canals F; Proteomics, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Vidal A; Department of Pathology. Hospital Universitari de Bellvitge-IDIBELL, CIBERONC, Barcelona, Spain., Piulats JM; Medical Oncology, Catalan Institute of Cancer (ICO), IDIBELL-Oncobell, Hospitalet de Llobregat, Spain., Matías-Guiu X; Department of Pathology. Hospital Universitari de Bellvitge-IDIBELL, CIBERONC, Barcelona, Spain., Brana I; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Muñoz-Couselo E; Melanoma and other skin tumors unit, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Garralda E; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Schlosser A; Rudolf Virchow Center, Center for Integrative and Translational Bioimaging, Julius-Maximilians-University Würzburg, Würzburg, Germany., Gros A; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jun 13; Vol. 29 (12), pp. 2250-2265.
Autor:
Ferrer-Mileo, L., Rodriguez Hernandez, A., Aversa, C., Rodríguez-Carunchio, L., Ribera, I., Trias Puigsureda, I., Oliva, L., Jimenez Blasco, N., García-Esteve, S., Álvarez, M., Rabella, M., Mellado Gonzalez, B., Torras, O. Reig
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S1220-S1221
Autor:
Galvao, V., Palomero, J., Creus-Gonzalez, I., Lostes Bardaji, M.J., Lozano-Rabella, M., Garcia-Garijo, A., Yuste, A., Rodriguez, L., Villalobos Alberú, X., Rotxes, M., Vieito Villar, M., Saavedra Santa Gadea, O., Alonso, G., Braña, I., Muñoz-Couselo, E., Querol, S., Tabernero, J., Martín-Lluesma, S., Gros, A., Garralda, E.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S650-S650
Autor:
Birulés I., López-Carrilero R., Cuadras D., Pousa E., Barrigón M.L., Barajas A., Lorente-Rovira E., González-Higueras F., Grasa E., Ruiz-Delgado I., Cid J., de Apraiz A., Montserrat R., Pélaez T., Moritz S., Ochoa S., Acevedo A., Anglès J., Argany M.A., Beltrán M., Bogas J.L., Camprubí N., Carbonero M., Carmona Farrés C., Carrasco E., Casañas R., Conesa E., Corripio I., Cortes P., Crosas J.M., Delgado M., Domínguez L., Escartí M.J., Escudero A., Esteban Pinos I., Figueras M., Franco C., García C., Gil V., Giménez-Díaz D., Gonzalez-Casares R., González Higueras F., González-Montoro M.L., González E., Grasa Bello E., Guasp A., Huerta-Ramos M.E., Huertas P., Jiménez-Díaz A., Lalucat L.L., Llacer B., López-Alcayada R., Lorente E., Luengo A., Mantecón N., Mas-Expósito L., Montes M., Murgui E., Nuñez M., Palomer E., Paniego E., Peláez T., Pérez V., Planell K., Planellas C., Pleguezuelo-Garrote P., Rabella M., Renovell M., Rubio R., San Emeterio M., Sánchez E., Sanjuán J., Sans B., Schilling L., Sió H., Teixidó M., Torres P., Vila M.A., Vila-Badia R., Villegas F., Villellas R.
Publikováno v:
Journal of Personalized Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background: Metacognitive training (MCT) has demonstrated its efficacy in psychosis. However, the effect of each MCT session has not been studied. The aim of the study was to assess changes in cognitive insight after MCT: (a) between baseline, post-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::20278ed48115ecd7b4db5ece68b66765
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096723846&doi=10.3390/jpm10040253&partnerID=40&md5=7845227a9e1cac585f3bb73e5201d8e7
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096723846&doi=10.3390/jpm10040253&partnerID=40&md5=7845227a9e1cac585f3bb73e5201d8e7
Autor:
Palomero J; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Panisello C; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Lozano-Rabella M; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Tirtakasuma R; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Díaz-Gómez J; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Grases D; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Pasamar H; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Arregui L; HUB-ICO-IDIBELL Biobank, Bellvitge Institute for Biomedical Research, L'Hospitalet de Llobregat, Spain., Dorca Duch E; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain., Guerra Fernández E; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain., Vivancos A; Cancer Genomics, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., de Andrea CE; Pathology, Clinica Universidad de Navarra, Pamplona, Spain.; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain., Melero I; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain.; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research IDISNA, Pamplona, Spain., Ponce J; Department of Gynaecology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain., Vidal A; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain., Piulats JM; Medical Oncology, Catalan Institute of Oncology (ICO), IDIBELL-OncoBell, L'Hospitalet de Llobregat, Spain., Matias-Guiu X; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain.; Pathology, Arnau de Vilanova University Hospital, University of LLeida, IRBLLEIDA, Lleida, Spain., Gros A; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain agros@vhio.net.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Dec; Vol. 10 (12).
Autor:
Huerta-Ramos ME, Marcó-García S, Escobar-Villegas MS, Rubio-Abadal E, Ochoa S, Grasa Bello EM, Alonso Solís A, Rabella M, Berdun J, Hospedales M, M-Resist G, Corripio I, Usall J
Publikováno v:
ACTAS ESPANOLAS DE PSIQUIATRIA
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
BACKGROUND: Despite the theoretical potential of m-health solutions in the treatment of patients with schizophrenia, there remains a lack of technological solutions in daily practice. The aim of this study was to measure the receptivity of patients,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4188fff560a6a3928c8644f0f962dfa7
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13279
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13279
Autor:
Huerta-Ramos, E, Marco-Garcia, S, Escobar-Villegas, MS, Rubio-Abadal, E, Ochoa, S, Bello, EMG, Solis, AA, Rabella, M, Berdun, J, Hospedales, M, Corripio, I, Usall, J
Publikováno v:
ACTAS ESPANOLAS DE PSIQUIATRIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universitat Pompeu Fabra
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universitat Pompeu Fabra
Background. Despite the theoretical potential of m-health solutions in the treatment of patients with schizophrenia, there remains a lack of technological solutions in daily practice. The aim of this study was to measure the receptivity of patients,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::14dd52d7e6d7dc8f2543474ad0c61e3d
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14100
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14100